BAYN.XETRA Bayer AG NA

Healthcare Pharmaceuticals XETRA Stock Exchange
56.22 EUR
Close of Nov 6, 2026
26.10 56.60
Market cap
EUR 55.2B
P/E
-
P/B
1.83x
ROE
10.6%
Dividend yield
0.23%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BAYN.XETRA undervalued?

Graham number

The Graham number of Bayer AG NA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bayer AG NA fundamental analysis

No fundamental analysis for Bayer AG NA yet.

Bayer AG NA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bayer AG NA

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and d…

Full company profile